Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R A De Man

Showing results (1-10 of 161) with videos related to

Pageof 17
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|November 21, 2007
[Hepatitis B and C: in view of the treatment options, priority should be given to reaching the groups at risk]R A de Man
Nederlands Tijdschrift Voor Geneeskunde|March 15, 1997
[Severe hepatitis attributed to paroxetine (Seroxat)]R A de Man
Expert Opinion on Investigational Drugs|April 1, 2003
Entecavir: a potent new antiviral drug for hepatitis BP Honkoop, R A De Man
Nederlands Tijdschrift Voor Geneeskunde|March 15, 2003
[Evaluation of the Rotterdam guideline for referral in case of chronic hepatitis B: improvement possible via a shortening of the referral chain and better distribution of information]M C Mostert, J H Richardus, R A de Man
Endoscopy|April 21, 1998
Laparoscopy as a day-case procedure in patients with liver diseaseG Unal, H R van Buuren, R A de Man
Nederlands Tijdschrift Voor Geneeskunde|April 3, 1993
[Acute liver failure caused by methylenedioxymethamphetamine ('ecstasy')]R A de Man, J H Wilson, H S Tjen
European Journal of Gastroenterology & Hepatology|December 14, 2001
Nucleoside analogues for chronic hepatitis BL M Wolters, H G Niesters, R A de Man
The Netherlands Journal of Medicine|September 25, 2007
Ascites in cirrhosis: a review of management and complicationsJ J Kuiper, H R van Buuren, R A de Man
Alimentary Pharmacology & Therapeutics|January 8, 2008
Review article: Success and failure of nucleoside and nucleotide analogues in chronic hepatitis BW F Leemans, M J Ter Borg, R A de Man
Alimentary Pharmacology & Therapeutics|January 8, 2008
Review article: Management of ascites and associated complications in patients with cirrhosisJ J Kuiper, R A de Man, H R van Buuren
Pageof 17

Showing results (1-10 of 161) with videos related to

Sort By:
Pageof 17
Nederlands Tijdschrift Voor Geneeskunde|November 21, 2007
[Hepatitis B and C: in view of the treatment options, priority should be given to reaching the groups at risk]R A de Man
Nederlands Tijdschrift Voor Geneeskunde|March 15, 1997
[Severe hepatitis attributed to paroxetine (Seroxat)]R A de Man
Expert Opinion on Investigational Drugs|April 1, 2003
Entecavir: a potent new antiviral drug for hepatitis BP Honkoop, R A De Man
Nederlands Tijdschrift Voor Geneeskunde|March 15, 2003
[Evaluation of the Rotterdam guideline for referral in case of chronic hepatitis B: improvement possible via a shortening of the referral chain and better distribution of information]M C Mostert, J H Richardus, R A de Man
Endoscopy|April 21, 1998
Laparoscopy as a day-case procedure in patients with liver diseaseG Unal, H R van Buuren, R A de Man
Nederlands Tijdschrift Voor Geneeskunde|April 3, 1993
[Acute liver failure caused by methylenedioxymethamphetamine ('ecstasy')]R A de Man, J H Wilson, H S Tjen
European Journal of Gastroenterology & Hepatology|December 14, 2001
Nucleoside analogues for chronic hepatitis BL M Wolters, H G Niesters, R A de Man
The Netherlands Journal of Medicine|September 25, 2007
Ascites in cirrhosis: a review of management and complicationsJ J Kuiper, H R van Buuren, R A de Man
Alimentary Pharmacology & Therapeutics|January 8, 2008
Review article: Success and failure of nucleoside and nucleotide analogues in chronic hepatitis BW F Leemans, M J Ter Borg, R A de Man
Alimentary Pharmacology & Therapeutics|January 8, 2008
Review article: Management of ascites and associated complications in patients with cirrhosisJ J Kuiper, R A de Man, H R van Buuren
Pageof 17